V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007001 | 300005072 | 1.69 | null | Palliative (P) | 2017-11-13 | 2017-11-13 | Oxaliplatin + Modified de Gramont | 02 | null | 300025710 | TRIAL |
| 300007002 | 300005072 | 0 | null | Palliative (P) | 2017-02-04 | 2017-03-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 300025710 | OXALIPLATIN + MDG |
| 300007003 | 300005074 | 1.68 | 76.2 | Curative (C) | 2015-02-08 | 2015-02-09 | Cisplatin | 2 | Y | 300025753 | CETUXIMAB + RT |
| 300007004 | 300005077 | 1.83 | 93 | null | 2014-12-05 | 2014-12-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300025753 | CHOP R + LIPOSOMAL DOX |
| 300007005 | 300005078 | null | 89.9 | Palliative (P) | 2015-08-06 | 2015-08-06 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 300025764 | CARBOPLATIN |
| 300007006 | 300007109 | null | 48 | Palliative (P) | 2016-08-22 | 2017-04-09 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | Y | N | 300025780 | CAPECITABINE |
| 300007008 | 300005080 | 1.84 | 85.8 | null | 2017-02-23 | 2017-03-27 | Trial Unspecified | 02 | N | 300025788 | CAPECITABINE + OXALIPLATIN |
| 300007009 | 300005081 | null | 67.6 | Neo-adjuvant (N) | 2015-11-24 | 2015-12-07 | Carboplatin AUC 2 - 5 | N | N | 300025788 | OXALIPLATIN + MDG |
| 300007010 | 300005083 | 1.59 | 81.9 | Palliative (P) | 2017-04-27 | 2018-01-06 | Folfirinox | N | N | 300025821 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007011 | 300005085 | 1.69 | 139 | Palliative (P) | 2018-01-31 | 2018-02-13 | Cisplatin | 2 | N | 300025827 | CARBOPLATIN |
| 300007012 | 300005085 | null | null | Palliative (P) | 2014-09-29 | 2014-10-05 | CETUXIMAB | 02 | null | 300025827 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007013 | 300005087 | 1.8 | 71 | Adjuvant (A) | 2014-04-17 | 2014-04-20 | GemCarbo Days 1+8 | N | N | 300025887 | IRINOTECAN + MDG |
| 300007014 | 300005087 | null | 60 | Curative (C) | null | 2014-05-01 | CETUXIMAB | Y | Y | 300025887 | CARBOPLATIN + RT |
| 300007015 | 300005087 | -1 | 110 | Palliative (P) | 2014-07-29 | 2014-08-27 | Trial Unspecified | N | N | 300025887 | CARBOPLATIN |
| 300007016 | 300005089 | 1.57 | 54.3 | Palliative (P) | 2017-10-24 | 2017-10-31 | Trial Unspecified | N | N | 300025905 | CETUXIMAB + CISPLATIN + FU |
| 300007017 | 300005089 | 1.77 | 79.3 | Palliative (P) | 2018-08-07 | 2018-08-08 | Capecitabine | N | N | 300025905 | OXALIPLATIN + MDG |
| 300007018 | 300005089 | 1.77 | 45.7 | Curative (C) | 2013-05-29 | 2013-07-01 | Capecitabine 35days + RT | Y | Y | 300025905 | CETUXIMAB + RT |
| 300007019 | 300005089 | 1.6 | null | Palliative (P) | 2016-05-27 | 2016-06-09 | Carboplatin + Cetux + FU (>Cycle 2) | Y | N | 300025905 | CARBO + FLUOROURACIL |
| 300007020 | 300005091 | null | 68 | Palliative (P) | 2014-05-10 | 2014-05-10 | FLUOROURACIL | N | N | 300025947 | CARBOPLATIN + ETOPOSIDE |
| 300007021 | 300007116 | null | 47.4 | null | 2015-03-15 | 2015-05-09 | Capecitabine 42days + RT | N | Y | 300025951 | DE-ESCALATE TRIAL |
| 300007022 | 300007117 | 1.73 | 72.4 | Palliative (P) | 2014-03-24 | 2014-06-13 | CARBOPLATIN + FLUOROURACIL | 01 | N | 300025959 | OXALIPLATIN + MDG |
| 300007023 | 300005096 | 1.76 | 84.6 | Palliative (P) | 2012-06-21 | 2013-11-10 | null | N | N | 300025959 | CAPECITABINE |
| 300007026 | 300005098 | 1.78 | 52 | Curative (C) | null | 2016-08-30 | Capecitabine 35days + RT | N | Y | 300026013 | CISPLATIN |
| 300007027 | 300005099 | null | 108.25 | Palliative (P) | 2016-12-25 | 2017-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300026039 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007028 | 300005101 | 1.67 | 107 | Palliative (P) | 2015-07-07 | 2015-09-18 | Cisplatin | 2 | N | 300026044 | CAPECITABINE + GEMCITABINE |
| 300007029 | 300005101 | 1.71 | 56.6 | Palliative (P) | null | 2015-04-19 | Gemcitabine + Capecitabine | N | N | 300026044 | OXALIPLATIN + MDG |
| 300007030 | 300005102 | 1.7 | 95.4 | Palliative (P) | 2014-08-22 | 2015-01-24 | CAPECITABINE + OXALIPLATIN | 02 | N | 300026081 | GEMCITABINE + OXALIPLATIN |
| 300007034 | 300005105 | 1.7 | 59 | Palliative (P) | 2014-05-11 | 2014-05-21 | Carboplatin AUC 2 - 5 | 02 | N | 300026114 | CAPECITABINE + OXALIPLATIN |
| 300007035 | 300005106 | 1.52 | null | Curative (C) | null | 2014-03-13 | CAPECITABINE + OXALIPLATIN | N | N | 300026125 | OXALIPLATIN + MDG |
| 300007038 | 300005109 | null | 76 | Disease modification (D) | 2016-10-02 | 2016-10-02 | Carbo F | Y | N | 300026151 | CARBOPLATIN + PACLITAXEL |
| 300007039 | 300005110 | 1.64 | 82 | Palliative (P) | 2013-06-25 | 2013-08-04 | Gemcitabine + Capecitabine | N | N | 300026152 | GEMCARBO |
| 300007040 | 300005110 | 1.67 | 56.8 | Palliative (P) | 2015-09-17 | 2016-04-08 | Oxaliplatin + Modified de Gramont | 02 | N | 300026152 | IRINOTECAN + MDG |
| 300007041 | 300005111 | 1.49 | 65.4 | Curative (C) | 2014-01-15 | 2014-02-05 | Carboplatin AUC 6 - 10 | N | null | 300026170 | CARBOPLATIN + PACLITAXEL |
| 300007042 | 300007129 | null | 49.6 | Palliative (P) | 2015-07-19 | 2015-07-20 | Trial Unspecified | N | N | 300026170 | CISPLATIN |
| 300007043 | 300005115 | 1.76 | 101 | null | 2016-12-10 | 2016-12-16 | CARBOPLATIN + RT | N | N | 300026189 | CARBO + FLUOROURACIL |
| 300007044 | 300005115 | 1.63 | null | Palliative (P) | 2014-08-15 | 2015-09-28 | Cisplatin 7 day | 2 | Y | 300026189 | CETUXIMAB + RT |
| 300007045 | 300005116 | 1.73 | 58 | Palliative (P) | 2017-12-12 | 2017-12-24 | Cisplatin | 02 | N | 300026233 | ESPAC TRIAL |
| 300007046 | 300005117 | 1.81 | 96.5 | Palliative (P) | 2015-04-16 | 2015-05-18 | Cetuximab 7 day (>Cycle 2) | Y | Y | 300026234 | CETUXIMAB |
| 300007047 | 300007132 | 1.55 | null | Neo-adjuvant (N) | 2017-02-15 | 2017-03-28 | Capecitabine | 02 | N | 300026242 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007048 | 300005119 | 1.59 | 60 | Palliative (P) | 2016-10-03 | 2016-10-18 | Cetuximab 7 day (Cycle 1) | 2 | N | 300026264 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300007049 | 300005121 | 1.6 | 79.6 | Palliative (P) | 2017-01-29 | 2017-01-29 | Cetuximab 7 day (Cycle 1) | 2 | N | 300026280 | BCG |
| 300007050 | 300005123 | 1.8 | 81 | Curative (C) | 2013-02-12 | 2013-09-27 | Capecitabine | N | N | 300026294 | CISPLATIN |
| 300007051 | 300005124 | null | null | Palliative (P) | 2015-04-26 | 2015-04-26 | Capecitabine | N | N | 300026300 | GEMCARBO |
| 300007052 | 300005125 | 1.63 | null | Adjuvant (A) | 2015-02-16 | 2015-03-05 | CETUXIMAB + RT | N | Y | 300026302 | DE-ESCALATE TRIAL |
| 300007053 | 300007135 | 1.55 | 73.9 | Palliative (P) | 2013-08-01 | 2013-12-23 | Gemcitabine + Oxaliplatin | 02 | null | 300026305 | TRIAL |
| 300007054 | 300005126 | 1.49 | null | Disease modification (D) | 2016-11-15 | 2016-12-06 | CARBOPLATIN + PACLITAXEL | N | null | 300026310 | ESPAC TRIAL |
| 300007055 | 300007136 | 1.8 | 67.6 | Neo-adjuvant (N) | 2013-07-10 | 2013-07-17 | MITOTANE | N | N | 300026320 | OXALIPLATIN + MDG |
| 300007056 | 300007136 | 1.46 | 60.6 | Palliative (P) | 2014-04-18 | 2014-05-31 | ESPAC-4 TRIAL | 2 | N | 300026320 | PEMBROLIZUMAB |
| 300007057 | 300005128 | 1.75 | 60.4 | Adjuvant (A) | 2017-09-02 | 2017-09-02 | CISPLATIN + FLUOROURACIL | 02 | Y | 300000030 | CISPLATIN |
| 300007058 | 300005128 | 1.58 | 52 | Palliative (P) | null | 2016-11-11 | GemCarbo Days 1+8 | N | N | 300000030 | CISPLATIN + FLUOROURACIL |